What are health, illness and healing?
Immune diseases and machine learning feature in new IMI Call for proposals
Today, the Innovative Medicines Initiative (IMI) is launching a new EUR 82 million Call for proposals focusing on immune diseases, imaging, machine learning, and digital clinical trials. The Call will give researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. Deadline for short proposals: 14 June 2018.
EDCTP contribution to epidemic preparedness: consortia ALERRT and PANDORA-ID-NET
Two networks on clinical research and response to emerging epidemics in sub-Saharan Africa have been presented on the occasion of the International Conference on (Re-)Emerging Infectious Diseases in Addis Ababa last 10-11 March 2018, and will have the support of EUR 20 million from the European Union and several European countries, as part of the European & Developing Countries Clinical Trials Partnership (EDCTP): the African coalition for Epidemic Research, Response and Training (ALERRT) and the Pan-African Network for Rapid Research, Response, Relief and Preparedness for Infectious Diseases Epidemics (PANDORA-ID-NET). The aim of the EDCTP is to reduce the health and socio-economic impact of disease outbreaks in sub-Saharan Africa.
Financing the next wave of medical breakthroughs – What works and what needs fixing?
Released today by the European Investment Bank and carried out under the Horizon 2020 Innovfin Advisory mandate, the study reviews the access-to-finance conditions for Life Sciences R&D and proposes solutions that could catalyse investments into the sector. The study finds that a lack of funding is limiting growth in European life sciences R&D. Purely market driven investment decisions by the private sector may leave important public health needs unaddressed. Aiming to ensure that all players can benefit from the deployment of innovative health technologies, the recommendations underline the importance of an investment vehicle at a time when innovative health technology markets have reached crossroads.
First set of top-class innovators selected for funding under the EIC pilot
A total of 57 small and medium-sized companies have been selected for funding under the recently launched European Innovation Council (EIC) pilot. The companies, selected following face-to-face interviews with a jury of innovators, entrepreneurs and venture capitalists, will receive a total amount of €94.25 million. Health SMEs are well represented in the list. The EIC pilot was launched in 2017 bringing together the parts of Horizon 2020 that provide funding, advice and networking opportunities for those at cutting edge of innovation.
The ICPerMed conference 2018 'Personalised Medicine in Action' announced
The first conference of the International Consortium for Personalised Medicine (ICPerMed) will take place on 20-21 November 2018 at the dbb forum in Berlin, Germany. The overarching focus will be on best practice examples of successful implementation of personalised medicine approaches. This will be complemented by high-level keynote talks addressing different aspects of personalised medicine. The EU-funded ICPerMed brings together around 40 European and international partners representing ministries, funding agencies and the European Commission. Its central aim is to align and encourage joint efforts in personalised medicine research and implementation on a European and international level.
Designer T cells to treat cancer: CARAMBA project takes the lead in CAR T cell immunotherapy of blood cancer
A new European research consortium CARAMBA will push a revolutionary approach for blood cancer treatment to clinical practice. The project aims to transfer the revolutionary immunotherapy with so-called CAR-T cells for the treatment of multiple myeloma, a rare and incurable hematologic malignancy, from bench to bedside. CAR-T cell therapy has been recognized as a ‘Breakthrough Therapy’ and clinical proof-of-concept obtained with CD19 CAR-T cells in leukemia and lymphoma.
Coordinated by the University Hospital Wuerzburg’s Department of Medicine, the international research programme gathers partners of six EU countries, among those four clinical centres of excellence for cancer treatment.
28 March 2018, Brussels, Belgium - Personalised Medicine and the Big Data Challenge
18 April 2018, Sofia, Bulgaria - Scaling up neuroscience: High performance computing and modelling the brain